Medtech software company Intelerad Medical Systems will be sold to a UK-based private equity firm that specializes in software and service businesses, according to its current owner, Novacap. The Canada-based private equity firm said it will sell Intelerad to Hg. The transaction is expected to close in the first quarter of 2020. Intelerad specializes in […]
Biotronik appoints new chief medical officer
Biotronik today said it appointed David Hayes as chief medical officer. Hayes will be responsible for overseeing the development of the company’s cardiovascular solutions and other innovations that can help physicians and health systems deliver patient care. “Our focus has always been on the patient. To help patients live their best lives, we remain in […]
How LED light can break down ingestible medical devices
Researchers at the Massachusetts Institute of Technology have developed an approach to break down ingestible medical devices in the gastrointestinal tract. Medical devices can be inserted in the gastrointestinal tract to treat, diagnose or monitor a number of GI disorders. However, the devices have to removed through endoscopic surgery once completed. The MIT researchers developed […]
Abbott wins expanded indication for Infinity DBS system
Abbott (NYSE:ABT) today announced FDA approval of an expanded indication for the company’s Infinity deep brain stimulation system. Abbott boasts that Infinity is now the only directional DBS system approved for all major targets used to treat movement disorders, Parkinson’s disease and essential tremor. The new indication is for targetting the brain’s internal globus pallidus (GPi), […]
NANS 2020: Neuromodulation news you need to know
Neuromodulation devices from companies including Medtronic (NYSE:MDT), Abbott (NYSE:ABT) and SPR Therapeutics are showing promise treating pain. That’s one of the initial takeaways from study results that medical device companies in the neuromodulation space are touting this weekend at NANS 2020 in Las Vegas. NANS is a joint conference of Congress of Neurological Surgeons and the […]
New 510(k) boosts iRhythm, Verily efforts for AFib screening
The latest 510(k) clearance for the Verily Study Watch will further the efforts of the Google sister company and iRhythm Technologies (NSDQ:IRTC) to improve atrial fibrillation treatment. Verily — a life science company under Alphabet (NSDQ:GOOGL) — recently received an FDA 510(k) clearance to include an irregular pulse monitor in its Study Watch wearable. “We’ve worked carefully […]
Hillrom shares slide despite topping Street forecast
Hillrom (NYSE:HRC) shares dipped today on first-quarter results that fell short of last year’s numbers but still topped the consensus forecast. The Chicago-based company posted profits of $39.8 million, or 59¢ per share, on sales of $685 million for the three months ended Dec. 31, 2019, for a 5.7% bottom-line slide on sales growth of 0.15%. […]
Edwards Lifesciences stock takes a hit on TAVR report
Edwards Lifesciences (NYSE:EW) shares are recovering a bit today — a day after the stock took a nearly 5% slide after a Jefferies report suggested a potential step down in TAVR sales in December. The Jefferies model showed a sharp step down in December growth (–2% to +3%) from October and November (+27–28%). The result was […]
Brainlab acquires VisionTree Software
Brainlab announced that it completed the acquisition of patient-centric data collection and health management company VisionTree Software. Munich, Germany–based Brainlab said the acquisition highlights the company’s commitment to taking a closer look at patient quality of life and condition post-treatment. San Diego–based VisionTree Software develops cloud-based data collection and health management solutions that Brainlab plans […]
Smith & Nephew buys Tusker Medical
Smith & Nephew (NYSE:SNN) today said it acquired Tusker Medical for an undisclosed amount. Tusker Medical develops the Tula System, which is an in-office ear tube delivery system to treat recurrent or persistent ear infections. The pediatric ear tubes won FDA breakthrough device designation in November last year. “The Tula System is a truly innovative option […]
FDA grants Medtronic an IDE to study new tech for ablating heart tissue
Medtronic (NYSE:MDT) announced today that it won FDA approval to move forward with an investigational device exemption trial to evaluate the safety and effectiveness of its PulseSelect pulsed-field ablation (PFA) system. The PulseSelect system is designed to use the pulsed electric fields to treat atrial fibrillation (Afib). It uses the fields to ablate or create lesions […]
- 1
- 2
- 3
- …
- 182
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube